Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales

Key TakeawaysBoston Scientific exceeded first-quarter profit and sales forecasts on demand for its cardiovascular devices.The results were lifted by regulatory approval and launch of its product to treat irregular heartbeats.The news sent shares of Boston Scientific to an all-time high. Shares of Boston Scientific (BSX) hit an all-time high Wednesday as the maker of medical equipment reported better-than-anticipated quarterly results and boosted its guidance on demand for its cardiovascular devices, includi ...